Terminal complement complexes in acute poststreptococcal glomerulonephritis.
Activation of the complement cascade occurs in most cases of acute poststreptococcal glomerulonephritis (APSGN) and results in the formation of the terminal complement complexes (TCC). To examine the possible role of TCC in the pathogenesis of glomerular injury in APSGN, we studied 30 patients with the clinical diagnosis of APSGN. All patients had an elevated plasma SC5b-9 concentration at the onset of clinical nephritis. Serial plasma concentrations showed an inverse linear relationship with time after onset of clinical disease (r = -0.59, P = 0.0008), while plasma C3 concentrations showed a positive linear relationship (r = 0.78, P = 0.0001). Renal biopsies of 5 patients demonstrated co-localization of C5b-9, S-protein, and C3 deposition in a glomerular capillary loop and mesangial distribution. Urinary excretion of TCC in the acute phase of APSGN was not elevated and was not a useful marker of disease activity. These data suggest that in APSGN with terminal complement pathway activation the local generation of TCC may contribute to the pathogenesis of the disease.
Matsell
D G
DG
Department of Pediatrics, University of Western Ontario, London, Canada.
Wyatt
R J
RJ
Gaber
L W
LW
D000208:Acute Disease; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003165:Complement System Proteins / Q000378:metabolism*; D003404:Creatinine / Q000097:blood / Q000652:urine; D005260:Female; D005921:Glomerulonephritis / Q000378:metabolism* / Q000382:microbiology* / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D008297:Male; D008856:Microscopy, Fluorescence; D013290:Streptococcal Infections / Q000150:complications* / Q000382:microbiology
D003165:Complement System Proteins; D003404:Creatinine